Envestnet Asset Management
FTXH icon

Envestnet Asset Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Envestnet Asset Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Sell
17,598
-716
-4% -$24.5K ﹤0.01% 3797
2025
Q4 		$603K Buy
18,314
+182
+1% +$5.67K ﹤0.01% 3574
2025
Q3 		$517K Buy
18,132
+367
+2% +$9.98K ﹤0.01% 3736
2025
Q2 		$455K Sell
17,765
-1,034
-6% -$26.2K ﹤0.01% 3763
2025
Q1 		$517K Buy
18,799
+2,396
+15% +$66.4K ﹤0.01% 3600
2024
Q4 		$442K Buy
16,403
+2,384
+17% +$66.9K ﹤0.01% 3648
2024
Q3 		$404K Buy
+14,019
New +$401K ﹤0.01% 3650
2022
Q2 		– Sell
-20,230
Closed -$538K – 3964
2022
Q1 		$538K Buy
+20,230
New +$522K ﹤0.01% 3083

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management's FTXH Position: Q1 2026 in Review

Envestnet Asset Management reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 3.9% in Q1 2026, selling an estimated $24.5K and leaving 17,598 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #3797.

Envestnet Asset Management first reported a position in FTXH in Q1 2022 and has held it in 8 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Envestnet Asset Management held 17,598 shares of First Trust Nasdaq Pharmaceuticals ETF worth $605K as of Q1 2026.
  • Envestnet Asset Management sold 716 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $24.5K.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #3797 holding.
  • Envestnet Asset Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2022 and has held it in 8 quarters since.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.